Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
Titel:
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
Auteur:
Zhu, Xiaofei Cao, Yangsen Liu, Wenyu Ju, Xiaoping Zhao, Xianzhi Jiang, Lingong Ye, Yusheng Jin, Gang Zhang, Huojun